Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5274 ARTÍCULOS , VIENDO DEL 676 AL 690

Elevated norepinephrine may interact with alpha-synuclein to promote Parkinson's disease and DLB

Fitzgerald PJ.

Acta Neurol Scand. 2022 Jan;145(1):3-4. doi: 10.1111/ane.13526.

A Critical Analysis of Quercetin as the Attractive Target for the Treatment of Parkinson's Disease

Acıkara OB, Karatoprak GŞ, Yücel Ç, Akkol EK, Sobarzo-Sánchez E, Khayatkashani M, Kamal MA, Kashani HRK.

CNS Neurol Disord Drug Targets. 2022;21(9):795-817. doi: 10.2174/1871527320666211206122407.

Robot-assisted gait training with auditory and visual cues in Parkinson's disease: A randomized controlled trial

Kim H, Kim E, Yun SJ, Kang MG, Shin HI, Oh BM, Seo HG.

Ann Phys Rehabil Med. 2022 May;65(3):101620. doi: 10.1016/j.rehab.2021.101620. Epub 2022 Feb 23.

Safety, Pharmacokinetics, and Pharmacodynamics of Oral Venglustat in Patients with Parkinson's Disease and a GBA Mutation: Results from Part 1 of the Randomized, Double-Blinded, Placebo-Controlled MOVES-PD Trial

Peterschmitt MJ, Saiki H, Hatano T, Gasser T, Isaacson SH, Gaemers SJM, Minini P, Saubadu S, Sharma J, Walbillic S, Alcalay RN, Cutter G, Hattori N, Höglinger GU, Marek K, Schapira AHV, Scherzer CR, Simuni T, Giladi N, Sardi SP, Fischer TZ; MOVES-PD Investigators.

J Parkinsons Dis. 2022;12(2):557-570. doi: 10.3233/JPD-212714.

Small Molecules Originated from Tryptophan and their Clinical Significance as Potential Biomarkers

Kowalik K, Miękus N, Bączek T.

Comb Chem High Throughput Screen. 2022;25(11):1809-1817. doi: 10.2174/1386207325666211216140240.

The influence of cerebrovascular disease in dementia with Lewy bodies and Parkinson's disease dementia

Hijazi Z, Yassi N, O'Brien JT, Watson R.

Eur J Neurol. 2022 Apr;29(4):1254-1265. doi: 10.1111/ene.15211. Epub 2022 Jan 20.

Treatment of Refractory Schizophrenia With Clozapine in a Patient With Wolff-Parkinson-White Syndrome

Cintrón Pastrana MA, Quintana Aviles E.

J Clin Psychopharmacol. 2022 Jan-Feb 01;42(1):95-96. doi: 10.1097/JCP.0000000000001494.

Effects of virtual reality-based motor rehabilitation: a systematic review of fMRI studies

Feitosa JA, Fernandes CA, Casseb RF, Castellano G.

J Neural Eng. 2022 Jan 24;19(1). doi: 10.1088/1741-2552/ac456e.

Acute-Onset Hemiparkinsonism Secondary to Subacute-Chronic Subdural Hematoma

Ozekmekci S, Ertan S, Cakmak OO, Senel GB, Peker S.

Turk Neurosurg. 2022;32(2):341-343. doi: 10.5137/1019-5149.JTN.34459-21.1.

The neuropsychiatry of Parkinson's disease: advances and challenges

Weintraub D, Aarsland D, Chaudhuri KR, Dobkin RD, Leentjens AF, Rodriguez-Violante M, Schrag A.

Lancet Neurol. 2022 Jan;21(1):89-102. doi: 10.1016/S1474-4422(21)00330-6.

Gradient biomimetic platforms for neurogenesis studies

Havins L, Capel A, Christie S, Lewis M, Roach P.

J Neural Eng. 2022 Jan 24;19(1). doi: 10.1088/1741-2552/ac4639.

Aerobic Exercise Alters Brain Function and Structure in Parkinson's Disease: A Randomized Controlled Trial

Johansson ME, Cameron IGM, Van der Kolk NM, de Vries NM, Klimars E, Toni I, Bloem BR, Helmich RC.

Ann Neurol. 2022 Feb;91(2):203-216. doi: 10.1002/ana.26291. Epub 2022 Jan 19.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias